Located in Fribourg, Switzerland, the BioFactory Competence Center (BCC) offers theoretical and practical training to biomanufacturers, and is set to launch a series of in-house courses next year focused on advances in continuous bioprocessing.
As such, the firm has selected Pall Life Sciences Cadence platform technologies for the hands-on training, as well as to equip a planned dedicated continuous bioprocessing training facility at the site.
“Pall and the BCC both have operations in Fribourg, and consequently, Pall have had a close collaboration since BCC commenced operations in January 2016,” Peter Levison, senior marketing director of downstream processing at Pall, told Biopharma-Reporter.
“We also share a common vision related to the importance of comprehensive technical training with a strong practical element that illustrates ‘real’ issues in bioprocessing.”
Continuous biomanufacturing
Pall is not the exclusive supplier of bioprocessing technologies, but the BCC will use its range of continuous production tech – including Pall’s Cadence Acoustic Separator for continuous clarification and separation, the Cadence BioSMB PD system for multi-column chromatography, and the Cadence Inline Concentrator for continuous concentration at various process steps – at the centre.
According to Levison, Pall is at the forefront of continuous bioprocessing through the development of its portfolio of continuous technologies, which covers all steps from harvest to formulation of the bulk mAb.
“Pall believes continuous bioprocessing philosophy will make a significant impact on the future of bioprocessing, so [is] investing in continuous ready technology and supporting associated education around continuous bioprocessing.”
He added: “Pall is looking to help facilitate the evolution of this paradigm. We certainly aim to keep ahead, but as you know this market does not stand still.”